"Lost Mary" Again Blocks Similar Trademark in the UK: “Love Mary” Found Likely to Cause Confusion

Aug.21
"Lost Mary" Again Blocks Similar Trademark in the UK: “Love Mary” Found Likely to Cause Confusion
The UK Intellectual Property Office has rejected Shenzhen Sendao Technology Co., Ltd.’s application to register the “Love Mary” trademark, siding with iMiracle (HK) Ltd., the owner of “Lost Mary.” The ruling determined that “Love Mary” was highly similar to “Lost Mary,” likely to mislead consumers, and risked damaging iMiracle’s established reputation and interests in the UK market.

 

Key Points:

 

Case Background:

  • Plaintiff (opponent): iMiracle (HK) Ltd. – owner of the “Lost Mary” brand.
  • Defendant (applicant): Shenzhen Sendao Technology Co., Ltd. – applied in 2022 to register the “Love Mary” trademark, covering e-cigarettes and related products.
  • iMiracle argued that “Love Mary” was too similar to “Lost Mary,” likely to confuse consumers.

 

Main Dispute:

  • The central issue was whether “Love Mary” would cause marketplace confusion.
  • iMiracle accused Sendao of attempting to exploit the reputation of “Lost Mary” through similarities in name, packaging, and typeface.
  • Sendao argued that “Love” and “Lost” conveyed different concepts sufficient for distinction.

 

Ruling:

  • The UK Intellectual Property Office ruled to reject Sendao’s “Love Mary” application, finding that it carried a risk of misleading consumers and potentially harming iMiracle’s reputation.
  • The decision emphasized that iMiracle had built strong market recognition and sales for “Lost Mary” in the UK since 2022, warranting legal protection.

 


 

According to a report by Law360 on August 20, the maker of the well-known disposable vape brand Lost Mary successfully won its case to block a competitor’s attempt to register the “Love Mary” trademark, on the grounds that it could mislead consumers into buying lookalike products.

 

“Love Mary” Trademark Rejected Due to High Risk of Confusion with “Lost Mary”

 

“A significant portion of consumers who have previously come into contact with the earlier mark are likely to fail to notice the differences, despite the conceptual distinction between ‘love’ and ‘lost,’” wrote hearing officer Rosie Le Breton in the ruling.

 

In 2022, Shenzhen Sendao Technology Co., Ltd. applied to register the “Love Mary” trademark for e-cigarettes, related tobacco products, filters, and lighters. iMiracle (also the manufacturer of the popular Elf Bar vapes) opposed the application, arguing that shoppers would confuse the two brands. The decision, dated August 11 and now made public, upheld iMiracle’s opposition.

 

The hearing officer noted that iMiracle had been selling e-cigarettes under the “Lost Mary” mark since March 2022 and that there was “no doubt” the company enjoyed significant market reputation.

 

The ruling further highlighted that in the seven months leading up to Sendao’s October 2022 application, iMiracle’s monthly revenue rose dramatically from £1 million (about US$1.3 million) to over £9 million.

 

The officer also found that Shenzhen Sendao Technology Co., Ltd.’s products used packaging and typeface similar to iMiracle’s, suggesting an intent to deceive consumers into mistakenly purchasing rival products.

 

Such conduct created an obvious risk of reputational harm to iMiracle, as dissatisfied customers might wrongly attribute negative experiences with Sendao’s products to iMiracle.

 

Moreover, the officer determined that the marks were very similar in appearance and sound, covering identical or highly similar products, and that both conveyed overlapping concepts since each referenced a character named “Mary.”

 

Even if some consumers noticed the difference between “Love” and “Lost,” a significant proportion would still be indirectly confused, perceiving the two as alternative product ranges from the same company.

 

The case was registered as O/0747/25 under trademark number 3841865, with Shenzhen Sendao Technology Co., Ltd. as applicant and iMiracle (HK) Ltd. as opponent.

 

Both iMiracle and Shenzhen Sendao Technology Co., Ltd. have not yet issued public comments on the ruling.

 

Comparison chart of Love Mary and Love Mary products | Chart made by: 2Firsts

 

iMiracle’s Continued Trademark Enforcement: Lawsuit Against “Found Mary”

 

This is not iMiracle’s first trademark defense in the UK market. The company previously sued Vapes-Bars Ltd., alleging that its “Found Mary” disposable vapes copied the appearance, name, and colors of “Lost Mary” to gain unfair advantage.

 

In August 2023, iMiracle filed a lawsuit against the UK-based brand Found Mary, arguing that its products were nearly identical to Lost Mary, infringing on iMiracle’s trademark rights.

 

iMiracle sought a court order to prohibit Vapes-Bars, the company behind Found Mary, from selling any e-cigarettes under the “Found Mary” brand in the UK and from misrepresenting its business as being connected to iMiracle.

 

At the time, Vapes-Bars claimed it had filed applications for five trademarks under the Found Mary name. iMiracle responded that it had already lodged oppositions or invalidity proceedings against all five.

 

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | SMOORE FEELM Focuses on Promoting Clear Tank  Series Solutions, Featuring High Power, High Puff Count, and Coolness Adjustment
Product | SMOORE FEELM Focuses on Promoting Clear Tank Series Solutions, Featuring High Power, High Puff Count, and Coolness Adjustment
FEELM brand has launched the 'LUCENT FUTURE' series of t Clear Tank e-cigarette solutions on Instagram. These solutions, showcased at the CHAMPS TRADE SHOWS in the U.S., feature t Clear Tank designs, with the AURA and DUO models emphasizing high puff count and powerful performance.
Aug.04 by 2FIRSTS.ai
From Combustion to Conversation: BAT’s Omni Platform Tackles Misconceptions About Nicotine — A 2Firsts Exclusive Interview
From Combustion to Conversation: BAT’s Omni Platform Tackles Misconceptions About Nicotine — A 2Firsts Exclusive Interview
Launched in 2024, BAT’s Omni platform aims to advance tobacco harm reduction, dispel misconceptions about nicotine, and accelerate the transition to a smokeless future through science. In this 2Firsts exclusive interview, BAT’s head of strategic and digital communications shares insights on Omni’s vision and global impact.
Jul.15
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. tobacco maker Cabbacis has secured a USPTO patent (No. 12,349,724) for oral vaporizer pods, effective until July 2038. With existing patents, its iBlend™ harm-reduction products—featuring low-nicotine and hemp blends—are now protected in over 30 countries and key global tobacco markets.
Jul.18 by 2FIRSTS.ai
PMI Launches Global Smoke-Free Travel Information Platform: 2Firsts Shares User Insights and Trend Analysis
PMI Launches Global Smoke-Free Travel Information Platform: 2Firsts Shares User Insights and Trend Analysis
Philip Morris International(PMI) has launched the world’s first smoke-free travel platform to address information gaps and regulatory uncertainties for adult nicotine users. 2Firsts reviews its age verification, journey-focused interface, advanced search, and user support, highlighting how it helps adults make compliant cross-border purchases.
Jul.11 by 2FIRSTS.ai
South Korea’s KT&G Pledges $290,000 to Support Tobacco Farmers’ Health Checks and Training Programs
South Korea’s KT&G Pledges $290,000 to Support Tobacco Farmers’ Health Checks and Training Programs
South Korea’s KT&G has announced a 400 million won (approximately USD 290,000) initiative to support tobacco farmers through health checkups and educational training programs. Demonstrating tangible support, company employees also joined farmers in the tobacco harvesting process.
Jul.01 by 2FIRSTS.ai
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International’s U.S. affiliate (PMI America) has released a new white paper stating that U.S. healthcare professionals hold serious misconceptions about smoke-free products, with nearly half incorrectly believing that nicotine causes cancer. As a result, smokers are being denied scientifically accurate harm-reduction advice. The report calls on the U.S. Food and Drug Administration (FDA) to deliver accurate information on smoke-free alternatives to physicians, so they can help adul
Aug.19 by 2FIRSTS.ai